Cyrus Poonawalla: The Son Of A Horse Breeder Who Didn't Follow His Family's Footsteps But Carved His Own Path And Now Has A Net Worth Of Rs 2,25,000 Crore
Cyrus Poonawalla founded the Serum Institute of India (SII) in 1966, which is today the world's largest vaccine manufacturer.
Jul 16, 2023, 13:04 PM IST
Covid-19 situation in India better than elsewhere: SII CEO Adar Poonawalla
Covid-19 In India: India is in a better position to tackle the Covid crisis because of the government, healthcare workers and a common goal to tame the virus, said SII CEO Adar Poonawalla.
Jan 09, 2023, 09:02 AM IST
'XBB variant may cause new Covid-19 wave': WHO warns as Indians ditch booster doses
"There are over 300 subvariants of Omicron. I think the one that is concerning right now is XBB, which is a recombinant virus. We had seen some recombinant viruses earlier. It is very immune-evasive, which means it can overcome the antibodies. So slightly that we may see another wave of infections in some countries because of XBB," WHO said.
Oct 21, 2022, 10:50 AM IST
People fed up of Covid-19 pandemic, no takers for booster jabs: SII CEO Adar Poonawalla
"Since December 2021, we have stopped the production of the Covishield vaccine. We had a stock of a few hundred million doses at that time and of that 100 million doses had already expired," Poonawalla said.
Oct 21, 2022, 09:02 AM IST
Good news! SII in talks with Novovax to develop vaccine against monkeypox, says Adar Poonawalla
The SII CEO Adar Poonawalla has said that the SII is in talks with Novovax to develop a messenger RNA (mRNA) vaccine for monkeypox soon
Jul 26, 2022, 19:04 PM IST
'Never been a better time to be vaccine manufacturer': Serum Institute planning to set up its 1st plant in Africa
Asked about concerns over the rise of monkeypox cases, Serum Institute of India Chief Executive Adar Poonawalla said he believed the "disease was not so infectious", Reuters reported.
May 24, 2022, 12:15 PM IST
India’s Covid-19 vaccine Covovax available for everyone above age of 12 years: Serum Institute CEO Adar Poonawalla
"A lot of you have asked if Covovax is available for adults. The answer is yes, it is available for everyone above the age of 12," Poonawalla tweeted.
May 05, 2022, 08:32 AM IST
Covid-19 fourth wave: SII slashes price of each dose of Covovax jab, check details here
SII’s Covovax was earlier included on the CoWin portal for inoculation of children aged 12-17 years at private vaccination centres.
May 03, 2022, 19:56 PM IST
NTAGI approves SII's Covid-19 vaccine Covovax for 12-17 age group, say sources
The National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, as per ANI.
Apr 29, 2022, 17:55 PM IST
Fourth wave of Covid-19 to hit India? Here's what Serum Institute's CEO Adar Poonawalla has to say
Speaking to reporters on the sidelines of the ‘Alternate Fuel Conclave’, the SII CEO said the reason behind the low number of Covid-19 cases at the moment is that the country chose the right vaccine.
Apr 04, 2022, 21:35 PM IST
Novovax Covid-19 vaccine gets emergency use nod for those aged between 12-18 years in India
According to an official statement released by Novovax, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by the Serum Institute of India (SII) under the brand name Covovax and is the first protein-based vaccine authorized for use in this age group in India.
Mar 23, 2022, 06:27 AM IST
SII's Covid-19 vaccine ‘Covovax’ gets emergency use nod for children aged above 12 years
"Novavax in global trials has demonstrated more than 90 per cent efficacy. Serum Institute of India`s brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly," SII CEO Adar Poonawala said in a tweet.
Mar 09, 2022, 18:41 PM IST
SII working to develop COVID-19 booster shot more effective against Omicron: Adar Poonawalla
SII Chief Executive Officer Adar Poonawalla said COVID vaccines for children aged above 3 years will be launched in the next 6 months.
Dec 15, 2021, 06:51 AM IST
SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns
SII sought approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccine is available in the country.
Dec 02, 2021, 10:47 AM IST
'Covovax not approved in country of origin yet': Govt panel seeks additional data from SII
The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant of market authorisation of Covovax for restricted use in emergency situations.
Nov 28, 2021, 13:01 PM IST
SII requests Centre to fast-track movement of increasing Covishield stock
Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII, is learnt to have recently communicated to the Union Health Ministry that it has a manufactured stock of 24,89,15,000 Covishield doses and it is increasing every day.
Nov 21, 2021, 20:09 PM IST
India allows export of 20 million Novavax COVID vaccine doses to Indonesia
The government has also decided to allow the export of 10 million doses of a licensed version of the AstraZeneca shot made by SII, branded Covishield, to the global vaccine-sharing programme COVAX, two sources said.
Nov 19, 2021, 06:59 AM IST
Vaccine hesitancy in India greatest threat in overcoming COVID-19 pandemic: SII CEO Adar Poonawalla
Adar Poonawalla’s family-owned company SII is preparing to resume exports to the COVAX international vaccine sharing program for the first time since April.
Nov 18, 2021, 14:36 PM IST
COVID-19: Serum Institute of India files for WHO Emergency Use Listing for its Covovax vaccine
Covovax will become SII's second coronavirus vaccine to get a WHO nod after Covishield.
Aug 21, 2021, 09:07 AM IST
Seized COVID vaccine vials not Covishield, Serum Institute tells Kolkata Police
Serum Institute has communicated to Kolkata Police that the seized vials with labels of Covishield vaccine in the fake vaccine case in Kolkata was not Covishield vaccine. For further examination, Kolkata Police has sent those vials to Drug Controller for chemical examination.
Jul 29, 2021, 19:34 PM IST
